Amylyx Pharmaceuticals, Inc.
AMLX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $225,178 | $58,085 | $59,764 | $77,391 |
| Short-Term Investments | $118,812 | $122,741 | $144,304 | $99,110 |
| Receivables | $232 | $203 | $300 | $447 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $9,161 | $5,861 | $11,776 | $12,484 |
| Total Curr. Assets | $353,383 | $186,890 | $216,144 | $189,432 |
| Property Plant & Equip (Net) | $5,875 | $6,257 | $2,072 | $2,732 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $983 | $1,451 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2,500 | $0 | $1,460 | $1,470 |
| Total NC Assets | $9,358 | $7,708 | $3,532 | $4,202 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $362,741 | $194,598 | $219,676 | $193,634 |
| Liabilities | – | – | – | – |
| Payables | $5,339 | $3,294 | $4,810 | $2,939 |
| Short-Term Debt | $981 | $665 | $1,055 | $1,518 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $19,471 | $17,465 | $12,067 | $23,949 |
| Total Curr. Liab. | $25,791 | $21,424 | $17,932 | $28,406 |
| LT Debt | $4,954 | $5,297 | $327 | $463 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $4,954 | $5,297 | $327 | $463 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4,954 | $5,962 | $1,382 | $1,981 |
| Total Liabilities | $30,745 | $26,721 | $18,259 | $28,869 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $11 | $9 | $9 | $7 |
| Retained Earnings | -$718,428 | -$684,042 | -$642,599 | -$606,692 |
| AOCI | $815 | $551 | $0 | -$92 |
| Other Equity | $1,049,598 | $851,359 | $844,007 | $771,542 |
| Total Equity | $331,996 | $167,877 | $201,417 | $164,765 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $362,741 | $194,598 | $219,676 | $193,634 |
| Net Debt | -$219,243 | -$52,123 | -$58,382 | -$75,410 |